Oligo now represents Pharus SICAV Biotech and Pharus SICAV Value funds in Switzerland

By August 16, 2017Uncategorized

Oligo is proud to announce that we are the appointed Swiss representative for the Pharus SICAV Biotech and Pharus SICAV Value funds.

Both funds are approved by FINMA for public distribution in Switzerland. Oligo provided all the support to Pharus Funds for the registration process with FINMA.